stockrowTenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
Follow THC
Alert me
Tenet Healthcare Corporation (THC) Revenue
Tenet Healthcare Corporation's revenue for fiscal 2025 was $21.3B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $22.2B. Over the past ten years it has ranged from $17.6B (fiscal 2020) to $21.3B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 3 consecutive fiscal years. Tenet Healthcare Corporation ranks 3rd of 47 Medical Care Facilities companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $21.3B | 3.07% |
| FY2024 | $20.7B | 0.54% |
| FY2023 | $20.6B | 7.25% |
| FY2022 | $19.2B | (1.60%) |
| FY2021 | $19.5B | 10.46% |
| FY2020 | $17.6B | (4.54%) |
| FY2019 | $18.5B | 0.91% |
| FY2018 | $18.3B | (4.52%) |
| FY2017 | $19.2B | (2.25%) |
| FY2016 | $19.6B | 5.30% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $5.6B | 0.05% |
| Jun 2026 | $5.6B | 4.84% |
| Mar 2026 | $5.4B | (2.88%) |
| Dec 2025 | $5.5B | 4.50% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $22.6B |
| THC Tenet Healthcare Corporation | $22.2B |
| UHS Universal Health Services, Inc. compare | $18.4B |
| DVA DaVita Inc. compare | $14.2B |
| EHC Encompass Health Corporation compare | $6.3B |
| PACS PACS Group, Inc. compare | $5.7B |
| ENSG The Ensign Group, Inc. compare | $5.7B |
| CHE Chemed Corporation compare | $2.7B |
| CON Concentra Group Holdings Parent, Inc. compare | $2.3B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on THC
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement